Gene Query: MRPL24

Dataset Description Geneva Score
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 37.23
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 37.23
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 34.72
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 28.36
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 28.36
Paxillin regulates genomic networks in prostate cancer [LNCaP] 24.02
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 23.56
Genome wide expression change in LCC2 and MCF-7 cells 22.11
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 21.58
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 21.04
Identification of transcription start sites for human A549 cell line using ReCappable-seq 19.71
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 19.65
Genome-wide functional assessment of enhancer activities in the human genome 18.41
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 15.93
Control of prostate tumour growth by the long non-coding RNA GHSROS 15.91
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 15.78
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 15.51
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 14.67
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 14.04
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 13.71
U1 snRNP telescripting regulates size-function stratified human genome 12.42
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 12.37
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 12.3
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 12.1
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 11.97
Lipid degradation promotes prostate cancer cell survival 11.97
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 11.65
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 11.6
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 11.05
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 11.02
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 11.01
Gene expression changes caused by KRAS in MCF-10A 10.84
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 10.83
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 10.83
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 10.81
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 10.81
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 10.46
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 10.44
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 10.43
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 10.39
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 10.38
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 10.35
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 10.23
SUV420H2 knockdown in PANC-1 10.16
Survival of pancreatic cancer cells lacking KRAS function 10.15
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 10.12
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 10.04
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 10.04
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 10.03
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 10.0
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 10.0
Tracking of dCas9-methyltransferase footprints 9.95
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 9.92
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 9.91
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 9.91
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 9.79
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 9.79
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 9.78
DART-seq: an antibody-free method for global m6A detection 9.72
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 9.62
Glioblastoma stem cells infected by ZIKA virus 9.61
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 9.61
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 9.59
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 9.57
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 9.55
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 9.55
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 9.53
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 9.53
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 9.41
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 9.37
O-glcnAc reprograms cellular energetics 9.27
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 9.27
Differential gene expression of human melanoma cells [RNA-seq] 9.17
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 9.17
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 9.16
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 9.16
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 9.13
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 9.0
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 8.98
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 8.97
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 8.88
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 8.82
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 8.79
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 8.77
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 8.77
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 8.76
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 8.76
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 8.72
Transcriptome sequencing of K-562 cells 8.69
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 8.6
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 8.58
Genome-wide transcriptional response to random aneuploidy in human cells 8.52
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 8.48
Impact of dieldrin on transcription in Jurkat T cells 8.33
miRNAs affected by antagomiR-17 treatment 8.29
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 8.27
Neurofibroma 8.27
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 8.26
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 8.2
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 8.15
Identification of HOXB13 target genes responsive to BET inhibitors 8.14
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 8.09
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 8.04
Hijacking of stress response machinery by oncogenes in acute leukaemia 8.04
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 8.04
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 8.0
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 7.84
A Unique Epigenomic Landscape Defines Human Erythropoiesis 7.84
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.82
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 7.79
Global analysis of enhancer targets: Mosaic-seq 7.79
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 7.79
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 7.79
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 7.69
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 7.63
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 7.62
HEK293 TFAM Knockout Expression Study 7.61
RNA-seq in transgenic cells 7.6
Gene expression changes after LOC550643 silencing 7.58
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 7.55
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 7.51
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 7.51
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 7.5
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 7.5
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 7.45
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 7.44
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 7.36
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 7.34
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 7.34
4sUDRB-seq: measuring transcription elongation and initiation genomewide 7.33
Transcriptome analysis of U87 cells upon LINC00152 knockdown 7.3
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 7.22
RNA seq comparison between scrambled and shGRP78 cells 7.18
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 7.17
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 7.17
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 7.15
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 7.05
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 7.0
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 6.97
ETV7 and interferon response 6.97
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 6.95
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 6.92
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 6.91
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 6.91
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 6.83
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 6.78
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 6.78
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 6.76
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 6.71
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.69
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 6.67
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 6.65
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 6.63
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 6.63
Identification of global regulators of T-helper cell lineage specification 6.63
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 6.61
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 6.61
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 6.58
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 6.56
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 6.56
Genome wide expression change by RNF168 knocking down in NEC cells 6.52
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 6.5
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 6.5
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 6.47
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 6.46
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 6.44
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 6.44
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 6.43
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 6.43
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 6.43
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 6.42
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 6.41
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 6.4
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 6.39
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 6.38
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 6.35
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 6.34
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 6.3
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 6.3
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 6.3
Human Treg IL-12 stimulation 6.29
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 6.27
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.26
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.26
Global gene expression profile of dasatinib-resistant RCH-ACV cells 6.18
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 6.18
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 6.17
Transcriptome profiling of Normal and Cancerous Prostate Cells 6.16
Epigenetic reprogramming of melanoma cells by vitamin C treatment 6.16
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 6.15
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 6.14
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 6.14
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 6.1
PRDM1 inhibits proliferation of human colon cancer organoids 6.07
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 6.06
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 6.03
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 6.02
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 6.02
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 6.02
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 6.02
Trans-differentiation of human adult peripheral blood T cells into neurons 5.95
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 5.95
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 5.95
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 5.93
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 5.89
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 5.88
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 5.85
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 5.83
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 5.83
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 5.81
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 5.81
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 5.79
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 5.78
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 5.74
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 5.74
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 5.7
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 5.69
Overexpression of NFIB and YBX1 in MCF-7 cells 5.69
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 5.69
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 5.63
Next Generation Sequencing of human SMA and healthy control Motor Neurons 5.61
Transcriptome-wide identification of CELF2 functional targets in T cells 5.61
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 5.57
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 5.57
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 5.57
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 5.55
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 5.51
Expression by CD133+ cells isolated from the adult human exocrine pancreas 5.5
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 5.47
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 5.45
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 5.43
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.42
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.42
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 5.37
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 5.37
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 5.36
Gene expression changes associated with resistance to tagraxofusp (SL-401) 5.35
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 5.33
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 5.31
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 5.31
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 5.22
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 5.2
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 5.18
Energy Metabolism during Anchorage-Independence 5.11
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 5.06
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 5.05
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 5.02
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 5.02
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 5.01
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 4.99
Mitochondrial dsRNA triggers antiviral signalling in humans 4.97
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 4.89
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 4.87
RNA-seq of cells with TET1 knockout 4.85
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.83
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 4.8
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 4.76
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 4.75
RNA editing in nascent RNA affects pre-mRNA splicing 4.74
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 4.71
ARS2 is a general suppressor of pervasive transcription [RNAseq] 4.7
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 4.69
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.68
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 4.62
Co-regulation of splicing by Rbfox1 and hnRNP M 4.61
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 4.61
RNA-seq of Single-Cell Genotyping of Transcriptomes 4.58
Single-Cell Genotyping of Transcriptomes 4.58
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 4.56
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 4.55
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 4.53
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 4.42
Gene expression signatures of innate lymphoid cells from human blood 4.42
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.41
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.41
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.41
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 4.41
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.39
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 4.34
Effect of PRDM11 depletion in U2932 cells 4.32
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 4.3
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 4.29
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 4.28
Single-cell analysis of adult human ovary using 10X genomics 4.25
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 4.25
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 4.25
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 4.24
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 4.24
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.24
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 4.23
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.22
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 4.16
RNA-seq analysis of control and Myc-induced U2OS cells 4.15
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 4.14
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 4.13
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 4.1
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 4.04
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 4.0
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 4.0
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 3.99
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 3.98
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 3.94
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.91
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 3.89
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 3.83
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 3.81
Transcriptional profiling of microglia; current state of the art and future perspectives 3.8
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 3.8
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 3.8
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 3.79
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 3.78
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 3.73
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 3.7
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 3.7
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 3.6
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.58
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 3.57
Regulatory network controlling tumor-promoting inflammation in human cancers 3.57
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.51
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 3.49
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 3.42
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 3.4
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 3.36
Ribosome profiling upon inhibition of eIF4A 3.35
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 3.33
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 3.32
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 3.32
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 3.27
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.25
RNA-seq analysis upon ARID1B overexpression 3.23
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.15
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.15
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 3.12
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.11
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.11
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.11
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 3.1
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 3.09
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 3.09
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.09
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 3.05
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 3.03
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 3.01
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 2.97
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 2.96
FBXW7 modulates stress response by post-translational modification of HSF1 2.96
Positively selected enhancer elements endow tumor cells with metastatic competence 2.96
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 2.96
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 2.96
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 2.94
RNAseq of cell lines with knocked in ESR1 mutations 2.93
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 2.91
AUF-1 affected genes in human skin cells 2.88
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.8
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 2.75
Comprehensive comparative analysis of 5’ end RNA sequencing methods 2.7
A transcriptome dataset revealing the molecular features of breast cancer stem cells 2.7
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 2.69
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 2.69
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 2.69
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 2.69
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 2.66
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.64
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.61
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 2.6
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.57
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.55
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 2.51
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 2.51
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 2.43
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 2.42
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 2.42
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.42
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 2.39
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.39
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 2.39
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 2.39
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 2.38
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 2.38
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.37
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.32
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 2.32
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.3
TT-Seq captures the human transient transcriptome 2.3
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.3
Copper Regulation of HIF-1 Transcription Activity 2.23
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.23
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.19
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.19
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.15
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.15
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.15
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 2.13
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 2.11
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 2.11
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 2.11
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 2.04
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.99
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.98
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.95
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.95
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.93
Gene expression profile of multiple myeloma cell lines treated with CB-5083 1.9
Gene expression analysis of human hepatocellular cancers 1.9
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 1.89
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 1.89
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.88
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.88
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.83
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.8
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 1.79
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 1.79
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 1.76
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.73
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.73
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 1.71
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.7
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.67
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.67
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.66
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.62
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 1.59
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 1.59
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.59
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 1.56
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 1.53
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.51
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 1.47
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.41
Single-cell analysis of human kidney organoids 1.38
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 1.36
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 1.35
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 1.35
RNA expression analysis upon JMJD1C depletion 1.35
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 1.33
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.3
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.27
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.27
Targeting MTHFD2 in Acute Myeloid Leukemia 1.25
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.2
Identification of the role of polydom in neurofibromas 1.19
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.19
Measure transcript integrity using RNA-seq data 1.13
MARCKS and lnc-MARCKS act as inflammation regulators 1.11
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.11
m6A-dependent regulation of messenger RNA stability 1.11
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 1.1
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 1.09
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.09
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.09
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.06
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 1.04
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.03
Function and hormonal regulation of GATA3 in human first trimester placentation 1.02
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.97
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 0.94
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 0.87
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.87
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.87
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.84
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.82
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.79
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.75
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.72
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.69
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.65
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.65
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.61
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.59
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.59
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.49
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 0.49
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.49
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.38
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.38
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.38
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.37
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.36
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.36
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.33
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.32
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 0.31
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.3
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.24
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.22
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.17
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.17
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 0.15
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.14
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.13
RNA-Seq and expression data from human adipose tissue 0.13
Transcriptome-wide modulation of splicing by the exon junction complex 0.12
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.11
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.09
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.09
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.07
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.05
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 0.03
Transcriptomic analysis of LSD1 0.0
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation